Hillsboro County, Florida. -According to the Johns Hopkins School of Medicine, hyperbaric oxygen therapy has been used in the United States since the beginning of the 20th century. The US Food and Drug Administration lists decompression sickness, burns, and carbon monoxide poisoning as diseases that the agency has approved to treat with HBOT. Now, some people say that it can ease the pressure of COVID-19 long-distance porters.

Jennifer Lind from Riverview said she was one of the successful examples.

Linde recently took her dog Dinah Jane Maloney for a jogging around the neighborhood. After that, she said: "Things have developed to such a point that I can't take her for a walk nearby, I can only take her out."

After recovering from COVID, Lind found that he was one of the half of the survivors that Penn State University researchers said, and they had long-term COVID symptoms. She said that shortness of breath was her main problem. Even the small things like cleaning the front porch can make her breathless.

"I do feel a big difference. Before, I might have to scan a few times and then sit down." Linde said.

Linde said the difference started at the Subsea Oxygen Clinic in Tampa. Doctor Joseph Dituri is the director of the clinic. He said that 10 patients with long-term symptoms of new coronary pneumonia, including headaches, drowsiness and brain fog, have come to the hyperbaric oxygen chamber of his clinic for treatment. Dituri said that each of them has improved their symptoms, and so far no one has come back.

"People will keep delaying, and we need to stop this," Diduri said of the prolonged COVID.

Linde said this was one of her fears.

She said: "It's horrible, because I feel that the rest of my life will be spent sitting on the sidelines and not being able to do what I like to do."

Dituri said that for long-term COVID, treatment to improve shortness of breath is the only quantifiable impact. Coronavirus is not one of the conditions approved by the FDA for HBOT treatment. Dituri said he hopes to see long-term changes. He said that HBOT has recorded anti-inflammatory results that can help counteract the systemic inflammatory response caused by COVID. Cases like Linde are part of a small retrospective study conducted by Ditturi on the ocean floor.

The director of the Department of Neurology at the University of South Florida Morsani School of Medicine said it may be difficult to prove that this treatment is helpful in treating neurological diseases such as brain fog.

Dr. Clifton Gucci said: "Actually, there is no research in the field of neurology that proves that hyperbaric oxygen therapy can reach such a high scientific standard in any specific disease." "Now, I am not talking about it. It will never work, we just need more evidence from randomized controlled trials to see if it will work."

Dituri also said that more research is needed. Finally, he said that he hopes that the work done on the seabed can help change the situation in the industry and how to use hyperbaric oxygen to treat diseases such as COVID for a long time.

The U.S. Food and Drug Administration said that clinical trials of HBOT for the treatment of COVID-19 are currently underway.

About more HBOT news please click previous news...